• Tues news: Prostate cancer trials to watch. Merck’s subcutaneous Keytruda. Apellis sees positive in Astellas CRL. Future of Medicare price negotiations. JNJ psoriasis results. See more on our front page

I Hate This Company

So do I. More and more with each passing day. It's a bunch of criminals leading a bunch of complete idiots. Thank God for my second job. I'm not sure how much longer I can stand this vomit pit.